How Top LAAO Programs Scale Faster: Efficiency, Workflow, and Growth Strategies

Aero IVL: The Device Upgrade Changing Coronary Calcium Modification- Case Reviews

For years, the biggest limitation of coronary IVL wasn’t its ability to modify calcium- it was deliverability. In this MurmurMD discussion, Dr. Yousif Ahmad and Dr. Chris Brown review early real-world experience with Aero, ⁨@ShockwaveMedical⁩ IVL platform designed to improve crossability, flexibility, rewrap, and treatment efficiency in calcified coronary anatomy. The discussion focuses on how Aero changes day-to-day decision-making around calcium modification, including: • Why deliverability has historically limited IVL use • How Aero’s tapered tip, redesigned shaft, flexible balloon material, and longer hydrophilic coating improve performance • Why 120 pulses matter for longer calcified segments • Delivering Aero through tortuous LAD/diagonal anatomy • Using Aero in heavily calcified distal left main bifurcation anatomy • When atherectomy is still needed before IVL • Why rewrap performance may be one of Aero’s biggest advantages • Treating multiple vessels with the same IVL balloon • Reduced need for guide extension, repeat balloons, and device exchanges • How Aero may shift IVL earlier in the calcium-modification algorithm This is a practical device-focused discussion on how a seemingly incremental design change may meaningfully change how operators approach complex coronary calcium. 🔔 Subscribe for more insights from interventional experts and real-world program builders. 📱 Download the app: https://apps.apple.com/app/apple-store/id1586692687 📺 Follow us on YouTube: https://www.youtube.com/channel/UCfrLYhAhliQ2ZvXinkDCZvA Chapters: 00:00 – Why Aero matters: IVL’s deliverability limitation 01:00 – What changed: tip, shaft, coating, and balloon design 02:00 – Tortuous LAD/diagonal anatomy and Aero deliverability 04:00 – When Aero may reduce the need for atherectomy 04:30 – Distal left main bifurcation calcium: atherectomy plus Aero 06:30 – Rewrap performance and multivessel treatment 08:00 – Fewer guide extensions, fewer exchanges, fewer ruptures 09:30 – How Aero may change the coronary calcium algorithm 11:00 – Final thoughts: why this upgrade surprised operators #Aero #IVL #IntravascularLithotripsy #CoronaryCalcium #CalcifiedLesions #LeftMain #Atherectomy #InterventionalCardiology #MurmurMD

How Transcatheter Arterialization of Deep Veins Saves Limbs with Dr. Vargas Estrada

What happens when a patient has critical limb-threatening ischemia, severe calcification, no distal targets, and has failed traditional endovascular therapy? In this MurmurMD discussion, Dr. Andres Vargas Estrada and Dr. Sameh Sayfo explain the evolution of Deep Vein Arterialization (DVA/TADV) and why it has become a powerful option for patients previously considered "no-option" candidates. The conversation explores the changing landscape of peripheral artery disease, the rise of small artery disease and medial arterial calcification, and why conventional therapies often fail in advanced CLTI patients. Key topics include: • Why today's CLTI patients are different than those of the past • The impact of diabetes, dialysis, and severe calcification • Understanding the MAC score and predicting treatment failure • Why traditional tibial interventions often fall short • The role of vessel preparation before advanced therapies • How Javelin, IVL, and bioresorbable scaffolds fit into modern limb salvage • The history and evolution of Deep Vein Arterialization • How DVA reroutes blood flow to preserve limbs when no arterial options remain This discussion highlights one of the most innovative shifts in peripheral intervention: when arteries can't be reopened, use the veins. 🔔 Subscribe for more insights from interventional experts and real-world program builders. 📱 Download the app: https://apps.apple.com/app/apple-store/id1586692687 📺 Follow us on YouTube: https://www.youtube.com/channel/UCfrLYhAhliQ2ZvXinkDCZvA Chapters: 00:00 – Why CLTI remains one of the biggest challenges in vascular care 03:00 – The shift from large artery disease to small artery disease 05:00 – Using the MAC score to identify no-option patients 07:00 – Modern tools: Javelin, IVL, and bioresorbable scaffolds 10:00 – The origins and evolution of Deep Vein Arterialization 13:00 – How DVA works and why it can salvage limbs 18:00 – Patient selection and practical considerations 22:00 – Future directions in limb salvage #DeepVeinArterialization #DVA #CLTI #LimbSalvage #PeripheralArteryDisease #Endovascular #PeripheralIntervention #CriticalLimbIschemia #MurmurMD

Removing Intracardiac Masses Without Surgery: Transcatheter Techniques Explained

Intracardiac masses have traditionally meant high-risk surgery — but transcatheter approaches are changing what’s possible in structural and endovascular intervention. In this MurmurMD discussion, Dr. Abdallah El Sabbagh and Dr. Andrei Pop review the evolving role of transcatheter removal of intracardiac masses, focusing on procedural planning, imaging guidance, device strategy, and patient selection. Key discussion points from the transcript include: • Types of intracardiac masses considered for transcatheter removal • Imaging strategies for procedural planning and guidance • Access considerations and device positioning • Managing embolic risk during extraction • Technical challenges unique to intracardiac mass removal • Patient selection and procedural decision-making • Real-world lessons from complex intracardiac cases • The expanding role of minimally invasive intracardiac intervention This discussion provides a practical look at how transcatheter techniques are creating new options for managing intracardiac masses without open surgery. 🔔 Subscribe for more insights from interventional experts and real-world program builders. 📱 Download the app: https://apps.apple.com/app/apple-store/id1586692687 📺 Follow us on YouTube: https://www.youtube.com/channel/UCfrLYhAhliQ2ZvXinkDCZvA Chapters: 00:00 – Why transcatheter intracardiac mass removal is evolving 01:30 – Imaging and procedural planning 03:30 – Access strategy and device positioning 05:30 – Managing embolic risk and technical challenges 07:30 – Patient selection and case considerations 09:00 – Key lessons and future direction #StructuralHeart #IntracardiacMass #TranscatheterIntervention #InterventionalCardiology #CardiacImaging #Endovascular #MurmurMD

How Top LAAO Programs Scale Faster: Efficiency, Workflow, and Growth Strategies

Building a successful LAAO program requires more than procedural skill — it depends on workflow efficiency, team coordination, and scalable systems. In this MurmurMD discussion, Dr. Vijay Iyer and Dr. Joe Walsh break down the key drivers behind LAAO program efficiency and growth, focusing on how high-performing programs optimize patient flow, referrals, procedural planning, and long-term expansion. Key discussion points from the transcript include: • Improving workflow efficiency in LAAO programs • Referral pathways and program growth strategies • Streamlining patient evaluation and scheduling • Building coordination across the heart team • Procedural efficiency and lab workflow optimization • Managing follow-up and longitudinal patient care • Identifying bottlenecks that slow program growth • Lessons learned from scaling successful LAAO programs This discussion provides practical insights into how structural heart teams can grow LAAO programs while improving efficiency and patient care. 🔔 Subscribe for more insights from interventional experts and real-world program builders. 📱 Download the app: https://apps.apple.com/app/apple-store/id1586692687 📺 Follow us on YouTube: https://www.youtube.com/channel/UCfrLYhAhliQ2ZvXinkDCZvA Chapters: 00:00 – Why LAAO program efficiency matters 01:30 – Referral pathways and program growth 03:30 – Streamlining workflow and patient evaluation 05:30 – Team coordination and procedural efficiency 07:30 – Managing follow-up and long-term care 09:00 – Lessons learned from scaling LAAO programs #LAAO #StructuralHeart #Watchman #LeftAtrialAppendageClosure #ProgramGrowth #HeartTeam #InterventionalCardiology #MurmurMD

Real-World Reintervention Rates Among TAVR Low-Risk Medicare Patients with Dr. Robert Yeh and Dr. Matthew Summers

As TAVR expands into younger and lower-risk patients, one question continues to drive decision-making: how durable are transcatheter valves over time? In this MurmurMD discussion, Dr. Robert W. Yeh reviews his late-breaker at CRT26, the Evolut valve durability data, focusing on long-term outcomes and what they mean for real-world clinical practice with Dr. Matthew Summers. Key insights from the transcript include: • Long-term performance of self-expanding Evolut valves • How durability is assessed and measured over time • Structural valve degeneration and clinical relevance • Comparing durability expectations in TAVR vs surgical valves • Patient selection and lifetime management considerations • What durability data means for younger TAVR patients • How evolving evidence may shape future practice This discussion provides a focused look at how durability data is influencing TAVR decision-making today and into the future. 🔔 Subscribe for more insights from interventional experts and real-world program builders. 📱 Download the app: https://apps.apple.com/app/apple-store/id1586692687 📺 Follow us on YouTube: https://www.youtube.com/channel/UCfrLYhAhliQ2ZvXinkDCZvA Chapters: 00:00 – Why valve durability matters in TAVR 01:00 – Overview of Evolut durability data 02:30 – Structural valve degeneration and outcomes 04:30 – Comparing TAVR vs surgical durability 06:00 – Clinical implications for patient selection 07:30 – Key takeaways and future direction #TAVR #Evolut #ValveDurability #StructuralHeart #AorticStenosis #InterventionalCardiology #MurmurMD